These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6372175)

  • 1. Considerations in the interpretation of animal bioassays for chemical carcinogenicity.
    Griesemer RA
    Transplant Proc; 1984 Apr; 16(2):412-5. PubMed ID: 6372175
    [No Abstract]   [Full Text] [Related]  

  • 2. 2nd International symposium of the Society of Toxicologic Pathologists. Design of carcinogenicity studies: considerations in pathology interpretation. May 9-11, 1983, Arlington, Virginia.
    Toxicol Pathol; 1983; 11(1):28-95. PubMed ID: 6681393
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward a classification scheme for degrees of experimental evidence for the carcinogenicity of chemicals for animals.
    Griesemer RA; Cueto C
    IARC Sci Publ; 1980; (27):259-81. PubMed ID: 6893701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinogenicity studies in experimental animals. II. Interpretation of the results and significance for man].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1051-4. PubMed ID: 3724898
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of carcinogenicity studies with aldrin and dieldrin.
    Ritper DL
    J Assoc Off Anal Chem; 1979 Jul; 62(4):900-3. PubMed ID: 500539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinogenicity studies in experimental animals. I. Design and performance].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1049-51. PubMed ID: 3724897
    [No Abstract]   [Full Text] [Related]  

  • 7. Aquatic animal bioassays for carcinogenesis.
    Black JJ
    Transplant Proc; 1984 Apr; 16(2):406-11. PubMed ID: 6719546
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical carcinogens: screening, testing, risk assessment for man.
    Schramm T; Teichmann B
    Neoplasma; 1981; 28(2):129-31. PubMed ID: 7254431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of cancer assays for pharmaceutical agents.
    Meyers DB; Young SS; Gries CL
    J Natl Cancer Inst; 1985 May; 74(5):1151-2. PubMed ID: 3858583
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2nd International symposium of the Society of Toxicologic Pathologists. Design of carcinogenicity studies: considerations in pathology interpretation. May 9-11, 1983, Arlington, Virginia.
    Toxicol Pathol; 1983; 11(2):132-207. PubMed ID: 6681406
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to "use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity".
    Fears TR; Tarone RE
    J Toxicol Environ Health; 1977 Nov; 3(4):629-32. PubMed ID: 592430
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program.
    Huff JE; Moore JA
    Prog Clin Biol Res; 1984; 141():43-64. PubMed ID: 6718388
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of two sequential applications of initiators in the production of hepatomas in the rat: an examination of the Solt-Farber protocol.
    Potter VR
    Cancer Res; 1984 Jun; 44(6):2733-6. PubMed ID: 6722804
    [No Abstract]   [Full Text] [Related]  

  • 18. Future possibilities for shorter-term assays of carcinogenicity.
    Sivak A
    Transplant Proc; 1984 Apr; 16(2):403-5. PubMed ID: 6719545
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of statistics when examining lifetime studies in rodents to detect carcinogenicity.
    Salsburg DS
    J Toxicol Environ Health; 1977 Nov; 3(4):611-28. PubMed ID: 592429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.